NEC Group's blood testing service 'FonesVisuas' adopted by Royal Healthcare, a medical institution for high-net-worth individuals in Singapore
NQ Score
50/100
AI Summary (NQ-processed)
NEC's blood testing service adopted in Singapore.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: Which medical institution in Singapore has adopted the FonesVisuas Test service?
- A: Royal Healthcare, a medical institution based in Singapore and a subsidiary of Sojitz Corporation, has adopted the service.
- Q: Where is Royal Healthcare located within Singapore?
- A: Royal Healthcare is based in Novena, which is a medical hub located in Singapore.
- Q: How does the FonesVisuas service analyze and visualize the state of the body?
- A: The service analyzes proteins that change daily from a small amount of blood to visualize the body's current state.
- Q: What specific diseases can the FonesVisuas service predict the risk of developing?
- A: It predicts the risk of developing dementia, myocardial infarction, stroke, lung cancer, chronic kidney failure, and prostate cancer.
- Q: What is NEC's future plan regarding the expansion of the FonesVisuas service?
- A: NEC intends to expand the sales of FonesVisuas overseas, with a specific focus on the APAC region.